ARCHIVES

Legacy CEO Cheryl Healton says foundation could serve as funder for research on “potentially reduced-exposure products.”

This article is from The Cancer Letter archive.

Vol. 30 No. 41 | October 29, 2004

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved By NCI CTEP Last Month

December 31, 2010

Griesmer To Leave NTP, Will Return To Oak Ridge

March 28, 1980

NCI’s Goal To Increase Minority Participation In Trials, Sondik Says

May 5, 1995

Tipping Resigned Forom ACS Following Volunteer Discontent

September 27, 1991

Cancer Center Directors Say Collaboration, Funding, and Application of Best Practices Will Reduce the Burden of Cancer.

September 15, 2006

Pooled Analysis of Two LUX-Lung Trials Shows Prolonged Survival with Afatinib

June 27, 2014